Individual Cognitive Stimulation Therapy for people with mild to moderate dementia

Completed

• Conditions: dementia; Neurological - Dementias; Neurological - Alzheimer's disease

• Registration Number: ACTRN12616000827437
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1) mild to moderate dementia (Montreal Cognitive Examination score of 15 or more)
2)the person can have a ‘meaningful’ conversation;
3)the person can hear well enough to participate in a 1-to-1 discussion.
4)the person’s vision is good enough to see most pictures.
5)the person is likely to remain in a session for 45 minutes

NB: Carers do not participate in the intervention. However, the next of kin will provide consent given the person with dementia may have diminished capacity to provide informed consent; the person with dementia will provide assent to participate.

Exclusion Criteria

a recent acute medical illness such as stroke or heart attack within the past 6 weeks will not be eligible

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Person with dementia: Montreal Cognitive Assessment (MoCA)[12 weeks post treatment commencement];Person with dementia: Quality of life Alzheimer’s disease Scale (QoL- AD)[12 weeks post treatment commencement]

Secondary Outcome Measures

Name	Time	Method
Person with dementia: CNS Vital Signs (CNSVS, a computerised neurocognitive test battery)[12 weeks post treatment commencement];Person with dementia:Dementia Quality of Life (DEMQOL)[12 weeks post treatment commencement];Person with dementia: Geriatric Depression Scale (GDS-15)[12 weeks post treatment commencement];Person with dementia: Quality of the carer-patient relationship (QCPR)[12 weeks post treatment commencement];Carer of the person with dementia: Short Form-12 Health Survey (SF-12)[12 weeks post treatment commencement<br>];Carer of the person with dementia: Self-reported health related quality of life EQ-5D<br><br>[12 weeks post treatment commencement<br>];Carer of the person with dementia: Hospital Anxiety and Depression Scale (HDAS)<br>[12 weeks post treatment commencement<br>];Carer of the person with dementia: Quality of the carer-patient relationship (QCPR)[12 weeks post treatment commencement<br>]